Bortezomib in the Treatment of Multiple Myeloma
Multiple Myeloma (MM) is the second most common type of blood cancer, resulting from an overproduction of cancerous infection-fighting white blood cells, known as plasma cells. Plasma cells are a crucial part of the immune system responsible for the production of antibodies. Bortezomib is a promisin...
Clasificación: | Libro Electrónico |
---|---|
Autor Corporativo: | SpringerLink (Online service) |
Otros Autores: | Ghobrial, Irene M. (Editor ), Richardson, Paul G. (Editor ), Anderson, Kenneth C. (Editor ) |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Basel :
Springer Basel : Imprint: Springer,
2011.
|
Edición: | 1st ed. 2011. |
Colección: | Milestones in Drug Therapy,
|
Temas: | |
Acceso en línea: | Texto Completo |
Ejemplares similares
-
Apoptosome An up-and-coming therapeutical tool /
Publicado: (2010) -
Stem Cells and Cancer Stem Cells,Volume 3 Stem Cells and Cancer Stem Cells, Therapeutic Applications in Disease and Injury: Volume 3 /
Publicado: (2012) -
Apoptosis in Carcinogenesis and Chemotherapy Apoptosis in cancer /
Publicado: (2009) -
Transforming Growth Factor-Beta in Cancer Therapy, Volume I Basic and Clinical Biology /
Publicado: (2008) -
Drugs Affecting Growth of Tumours
Publicado: (2006)